thiazoles has been researched along with 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, T; Bar-Am, O; Bloch, K; Mandel, SA; Mechlovich, D; Vardi, P; Youdim, MB | 1 |
1 other study(ies) available for thiazoles and 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol
| Article | Year |
|---|---|
The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage.
Topics: Animals; Antioxidants; Apoptosis; Blotting, Western; Caspase 3; Catalase; Cell Line; Cell Survival; Coloring Agents; Cytochromes c; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Hydrogen Peroxide; Hydroxyquinolines; Insulin-Secreting Cells; Iron Chelating Agents; Membrane Potentials; Mitochondria; Monoamine Oxidase Inhibitors; Oxidants; Oxidative Stress; Piperazines; Rats; Signal Transduction; Tetrazolium Salts; Thiazoles | 2010 |